HIGHLIGHTS
- who: Marc Vogel from the Citizenship Switzerland have published the paper: Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study, in the Journal: (JOURNAL)
- what: The authors report preliminary findings at the four-week follow-up of an open-label cohort study on feasibility and safety of HAT with IN DAM, and the sociodemographic and medical characteristics of patients receiving this treatment form. Standardised DAM doses for reporting in this paper corresponded to oral morphine equivalent doses and were calculated using a factor of 1 for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.